Michigan Researchers to Study Neurofilament Light Chain Blood Levels as a Predictor of Multiple Sclerosis
source: pixabay.com

Michigan Researchers to Study Neurofilament Light Chain Blood Levels as a Predictor of Multiple Sclerosis

According to a publication from BioSpace, researchers from Michigan's Memorial Healthcare Institute for Neurosciences and Multiple Sclerosis are taking full advantage of recent technological advances in neurofilament light chain testing…

Continue Reading Michigan Researchers to Study Neurofilament Light Chain Blood Levels as a Predictor of Multiple Sclerosis
Biogen Releases The Latest Research Results Featuring its Multiple Sclerosis Drugs
qimono / Pixabay

Biogen Releases The Latest Research Results Featuring its Multiple Sclerosis Drugs

According to a story from sectorpublishingintelligence.co.uk, studies utilizing data gathered in the real-world treatment setting are highlighting the characteristics of two different therapies for multiple sclerosis (MS) developed by the…

Continue Reading Biogen Releases The Latest Research Results Featuring its Multiple Sclerosis Drugs

The Sudden Closure of Northwestern University’s Stem Cell Therapy Clinic Raises Questions That Remain Unanswered

According to a recent article in The Scientist, Northwestern Medicine’s successful autoimmune and immunotherapy program is winding down and will be closed by the end of the year. The program,…

Continue Reading The Sudden Closure of Northwestern University’s Stem Cell Therapy Clinic Raises Questions That Remain Unanswered
First Human Trial Completed for Experimental Scleroderma and Multiple Sclerosis Drug
stevepb / Pixabay

First Human Trial Completed for Experimental Scleroderma and Multiple Sclerosis Drug

According to a story from Financial Buzz, the drug developer Emerald Health Pharmaceuticals, Inc., recently announced that the company had completed a phase 1 clinical trial for its experimental drug…

Continue Reading First Human Trial Completed for Experimental Scleroderma and Multiple Sclerosis Drug
Potential Treatment for Multiple Sclerosis Demonstrates Good Safety and Tolerability in Early Trial
stevepb / Pixabay

Potential Treatment for Multiple Sclerosis Demonstrates Good Safety and Tolerability in Early Trial

According to a story from news.cision.com, the Swedish biotechnology company Cyxone recently announced positive results from the company's phase 1 clinical trial. This trial was testing the tolerability and safety…

Continue Reading Potential Treatment for Multiple Sclerosis Demonstrates Good Safety and Tolerability in Early Trial
NeuroGen to Host No-Charge Outpatient Stem Cell Therapy Consultation Camp in Chandigarh
Pexels / Pixabay

NeuroGen to Host No-Charge Outpatient Stem Cell Therapy Consultation Camp in Chandigarh

According to a publication from NewZNew, the NeuroGen Brain and Spine Institute in India plans on hosting an outpatient stem cell therapy consultation camp in Chandigarh on the last day…

Continue Reading NeuroGen to Host No-Charge Outpatient Stem Cell Therapy Consultation Camp in Chandigarh
Researchers Discover Unique Immune System Cells With Unique Properties in Multiple Sclerosis
allinonemovie / Pixabay

Researchers Discover Unique Immune System Cells With Unique Properties in Multiple Sclerosis

According to a story from BioPortfolio, a team of scientists associated with the University of Zurich and others have made a remarkable discovery that could reveal new information about the…

Continue Reading Researchers Discover Unique Immune System Cells With Unique Properties in Multiple Sclerosis

This Time a “First-of-its-Kind” Study is “Out of this World” on Board the Space Station

  As reported recently in PhysOrg by NASA, researchers aboard SpaceX CRS-18 cargo flight are focusing on what triggers Parkinson’s disease and multiple sclerosis, both neurodegenerative diseases. Researchers suspect that…

Continue Reading This Time a “First-of-its-Kind” Study is “Out of this World” on Board the Space Station

A Brief Discussion of How Cell and Gene Therapies are Being Improved for Future Generations

  While the last few years have seen major advances in all areas of the pharmaceutical industry, some of the newest and brightest talents are now focusing on cell and…

Continue Reading A Brief Discussion of How Cell and Gene Therapies are Being Improved for Future Generations

Research Team Identifies Diagnostic Errors in Three Classes of Disease Associated with a High Death Rate or Permanent Disability

  The number of people in the U.S. who are permanently disabled or who die each year as a result of misdiagnosis is estimated to be over 100,000. EurekAlert recently reported…

Continue Reading Research Team Identifies Diagnostic Errors in Three Classes of Disease Associated with a High Death Rate or Permanent Disability

A Plasma Shortage is Affecting Common Variable Immune Deficiency Patient’s Access to Treatment

Heather White Heather White is a 41-year-old woman who was diagnosed with common variable immune deficiency (CVID) back in 2004 after fighting frequent bouts of pneumonia. Doctors believe that she…

Continue Reading A Plasma Shortage is Affecting Common Variable Immune Deficiency Patient’s Access to Treatment
4 out of 5 Functional Neurological Disorder Patients Have Lasting Neurological Symptoms
source: pixabay.com

4 out of 5 Functional Neurological Disorder Patients Have Lasting Neurological Symptoms

  Functional neurological disorder is a conversion disorder. This type of complex disorder is often thought to be linked with psychological symptoms, serious stress, or mental distress. With functional neurological…

Continue Reading 4 out of 5 Functional Neurological Disorder Patients Have Lasting Neurological Symptoms